MYCIO Wealth Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MYCIO Wealth Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,519	Closed	-$118K	–	768
2016 Q3	$118K	Hold	6,519	–	–	0.02%	237
2016 Q2	$107K	Hold	6,519	–	–	0.02%	253
2016 Q1	$108K	Hold	6,519	–	–	0.02%	218
2015 Q4	$141K	Hold	6,519	–	–	0.03%	179
2015 Q3	$129K	Buy	+6,519	New	+$206K	0.03%	174

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MYCIO Wealth Partners's HZNP Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2016, closing a stake of 6,519 shares — an estimated $118K sold.

MYCIO Wealth Partners first reported a position in HZNP in Q3 2015 and held it in 5 quarters. The position peaked at $141K in Q4 2015. 234 funds tracked by Wall St. Rank hold HZNP as of Q4 2016.

MYCIO Wealth Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 6,519 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2016, an estimated $118K.
MYCIO Wealth Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 5 quarters.
MYCIO Wealth Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $141K in Q4 2015.
234 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.